By MICHAEL J. de la MERCED
The $1.4 billion deal will create a specialist in treatments for both neurological and heart diseases.
Published: February 27, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1DdVr5y
from WordPress http://ift.tt/1FxqwDH
via Hadi Aboukhater
No comments:
Post a Comment